Literature DB >> 25751033

Cerebrospinal fluid vascular endothelial growth factor.

Peter T Nelson1, Gregory A Jicha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25751033      PMCID： PMC4444778          DOI： 10.1001/jamaneurol.2015.34

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  11 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA.

Authors:  T Sobrino; M Millán; M Castellanos; M Blanco; D Brea; L Dorado; R Rodríguez-González; M Rodríguez-Yáñez; J Serena; R Leira; A Dávalos; J Castillo
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

3.  Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.

Authors:  William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Eve Pickering; Max Kuhn; Yu Chen; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2010-03-16       Impact factor: 17.088

4.  The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.

Authors:  Martina Bocchetta; Samantha Galluzzi; Patrick Gavin Kehoe; Eduardo Aguera; Roberto Bernabei; Roger Bullock; Mathieu Ceccaldi; Jean-François Dartigues; Alexandre de Mendonça; Mira Didic; Maria Eriksdotter; Olivier Félician; Lutz Frölich; Hermann-Josef Gertz; Merja Hallikainen; Steen G Hasselbalch; Lucrezia Hausner; Isabell Heuser; Frank Jessen; Roy W Jones; Alexander Kurz; Brian Lawlor; Alberto Lleo; Pablo Martinez-Lage; Patrizia Mecocci; Shima Mehrabian; Andreas Monsch; Flavio Nobili; Agneta Nordberg; Marcel Olde Rikkert; Jean-Marc Orgogozo; Florence Pasquier; Oliver Peters; Eric Salmon; Carmen Sánchez-Castellano; Isabel Santana; Marie Sarazin; Latchezar Traykov; Magda Tsolaki; Pieter Jelle Visser; Åsa K Wallin; Gordon Wilcock; David Wilkinson; Henrike Wolf; Görsev Yener; Dina Zekry; Giovanni B Frisoni
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

5.  The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.

Authors:  Timothy J Hohman; Susan P Bell; Angela L Jefferson
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

Review 6.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

7.  Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Authors:  Jasmine Nettiksimmons; Laurel Beckett; Christopher Schwarz; Owen Carmichael; Evan Fletcher; Charles Decarli
Journal:  Psychol Aging       Date:  2013-03

8.  Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.

Authors:  Liang-Hao Guo; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-17       Impact factor: 5.270

9.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

10.  Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke.

Authors:  Weihua Guan; Payaningal R Somanath; Anna Kozak; Anna Goc; Azza B El-Remessy; Adviye Ergul; Maribeth H Johnson; Ahmed Alhusban; Sahar Soliman; Susan C Fagan
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.